Speaking to PharmaDispatch yesterday, and following recently announced changes to its Board and Canberra-based secretariat, CEO Liz de Somer said the association's goal is to build a 'renewed momentum'. …
MA's Liz de Somer: 'Critical' to build a 'renewed momentum'
August 2, 2018 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
GSK therapy becomes first biologic subsidised for Australians with uncontrolled COPD
September 1, 2026 - -
Those who ask questions and critique the process are treated as people who question and critique the process
September 1, 2026 - - Latest News -
New Zealand to fund flu vaccines for all children under five from 2027
September 1, 2026 - - Latest News -
Trust and collaboration take centre stage as Australia confronts widening vaccine gaps
September 1, 2026 - - Latest News -
Six Australian infectious disease ventures share $10.48 million in Biointelect funding round
August 31, 2026 - - Latest News -
BLS posts record earnings as overseas expansion accelerates
August 31, 2026 - - Latest News -
Private hospitals sustain 230,000 jobs despite $756 million loss
August 31, 2026 - - Other Health